What are the impacts of COVID-19 and other respiratory-based diseases on neurological processes? A new observational study assesses the likelihood of Alzheimer’s, Parkinson’s, and stroke in people who contract COVID-19 as well as influenza and pneumonia.
The company’s investigational mRNA-1273.214 vaccine has now demonstrated significantly higher antibody titers against all tested variants.
Hospitalization rates increased significantly after sepsis, with 11.9% of survivors rehospitalized for recurrent sepsis, and 56.6% receiving outpatient anti-infective treatment.
The CDC announces both the Mayo Clinic and Labcorp begin testing for the virus.
The federal agency linked Big Olaf Creamery ice cream to the recent outbreak in Florida.
An active viral reservoir of COVID-19 spike protein was detected in 65% of patients with post-acute sequelae of COVID-19.
The overall sensitivity of rapid antigen tests was 63%. However, the tests had a limited ability to detect asymptomatic Omicron infections.
Health care workers in Italy infected with SARS-CoV-2 were less likely to develop long COVID symptoms if they were fully vaccinated and boosted with an mRNA vaccine, a recent study found.
Work group from infectious disease associations proposes prioritizing 6 areas of research to improve efficacy and precision of antibiotic therapy
Omicron significantly diminishes the protective abilities of both natural immunity and vaccine-granted immunity.
The report showed the protective benefits varied somewhat by cardiovascular disease subtype.
A positive recommendation now heads to the European Commission, which can grant marketing authorization for 27 European Union member states.
Research shows specific climate elements affect mosquito proliferation and can play a role in predictors of vector activity and insect control interventions.
From December 2020-September 2021, approximately 27 million COVID-19 infections, 1.6 million hospitalizations, and 235000 deaths were prevented by vaccination.
Treatment with the novel antiviral sabizabulin reduced COVID-19 death by 55.2% in hospitalized patients with moderate to severe disease.
In an age of COVID-19, it is difficult for clinicians and public health officials to pivot and think about obscure infections like Pneumonic plague. However, a case of this plague occurred in Wyoming, and the local public health officials offer some insights into the clinical care of the patient as well as communicating with close contacts.
The revised Emergency Use Authorization (EUA) for Paxlovid (nirmatrelvir and ritonavir) allows these providers to offer this COVID-19 therapy.
Dr. Arlene Sena and her team are working to develop a syphilis vaccine, “But we need to know what’s circulating worldwide first.”
We want YOU to take our survey and tell us which infectious disease topics you want covered.
Access to antifungal susceptibility testing (AFST) remains limited in the United States. Therefore, providers must recognize clinical situations where AFST will provide its greatest value. In the latest article from SIDP, infectious disease pharmacists offers some insights on this subject.
Investigational vaccine demonstrates efficacy against respiratory syncytial virus in trial with adults inoculated with active RSV.
The commitment to ending the HIV epidemic endures, despite drops in testing and new diagnoses during the COVID-19 pandemic.
This first study of the UK’s ongoing monkeypox outbreak reported the clinical and demographic features of 54 confirmed cases.
Here is a rundown of the most popular and significant stories we covered this past week.
All studies included in this research found a correlation between area-level racial prejudice and adverse health outcomes among racial and ethnic minority populations.
The federal agency has reported 1 death and 22 hospitalizations stemming back to January of 2021.
Maternal mortalities increased 33.3% during the COVID-19 pandemic, while overall deaths increased 22%. Excess deaths were most prevalent in Hispanic and Black mothers.
The submission is based off both non-clinical and clinical data, including results from the phase 2/3 EPIC-HR study.
A computational framework for estimating vaccine effectiveness based on genetic differences of SARS-CoV-2 variants showed promising results in a new study that verified the model with clinical trial data.
Emergency medicine physicians are leaving behind their emergency rooms and opening primary care practices, which does not necessarily translate to a smooth transition with some inherent challenges associated with training and expectations.
